J&J Says Rybrevant Combo Bests AstraZeneca's Tagrisso in Type of Lung Cancer
Here's How Much You Would Have Made Owning Amgen Stock In The Last 20 Years
Amgen (NASDAQ:AMGN) has outperformed the market over the past 20 years by 1.01% on an annualized basis producing an average annual return of 8.86%. Currently, Amgen has a market capitalization of $161
Novartis Boasts Scemblix Beats Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
Novartis Reports Positive Phase 3 Data for Remibrutinib for Chronic Hives
Moderna Wins FDA Approval for RSV Vaccine
Gilead's Trodelvy Falls Short in Significantly Improving Overall Survival in NSCLC